Does isolated Ehrlichia chaffeensis and Rickettsia typhi IgG positivity prove current coinfection?

In an 83-year-old man, concurrent Ehrlichia chaffeensis and Rickettsia typhi IgG reactivity must be interpreted as evidence of antibody exposure, not as a stand-alone diagnosis of active dual infection.

Antibody persistence and diagnostic meaning

• Prior E. chaffeensis infection can leave IgG detectable for months to years. A single positive result cannot date infection and may also reflect cross-reactivity with Anaplasma antibodies.
• R. typhi IFA IgG can similarly remain elevated for months to years. In a longitudinal study of 90 patients, the median IgG half-life was 177 days, and detectable antibody has been reported up to 2 years after infection.
• Therefore, dual IgG positivity may reflect remote, separate infections, nonspecific reactivity, or limitations of serologic specificity rather than ongoing simultaneous disease.

Establishing acute infection

• Current infection should be demonstrated independently for each organism. The most informative serologic evidence is paired acute and convalescent pathogen-specific testing, collected weeks apart and preferably performed by the same laboratory.
• Seroconversion or a ≥4-fold increase in IgG titer for both E. chaffeensis and R. typhi supports contemporaneous acute infection.
• PCR detection of each pathogen early—particularly during the first illness week—provides direct support for active coinfection. A negative PCR later in illness or after antibiotics does not reliably exclude infection.
• IgM is not a dependable tie-breaker: it may be nonspecific, cross-reactive, persistent, or appear inconsistently relative to IgG.

Bottom line

• E. chaffeensis and R. typhi IgG can persist after prior infection; isolated dual IgG positivity should not be treated as proof of current coinfection without independent acute evidence for both pathogens.